Forecasting Asparaginase Need and Cost for Childhood Cancer Using ACCESS FORxECAST
PURPOSEAsparaginase (ASN) is a critical component of pediatric ALL protocols. Until recently, ASN was available in three formulations: native Escherichia coli, PEGylated E. coli (PEG), and Erwinase, with native E. coli typically more accessible in low- and middle-income countries (LMICs). Short shel...
Saved in:
Main Authors: | Terence M. Hughes, Nitin Shrivastava, Lewis B. Silverman, A. Lindsay Frazier, Sumit Gupta, Avram Denburg |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society of Clinical Oncology
2025-01-01
|
Series: | JCO Global Oncology |
Online Access: | https://ascopubs.org/doi/10.1200/GO-24-00444 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cerebral Sinus Venous Thrombosis due to Asparaginase Therapy
by: Youssef Alsaid, et al.
Published: (2013-01-01) -
A Study on L-Asparaginase of Nocardia levis MK-VL_113
by: Alapati Kavitha, et al.
Published: (2012-01-01) -
Recent advances in L-Asparaginase enzyme production and formulation development for acrylamide reduction during food processing
by: Arindam Jana, et al.
Published: (2025-01-01) -
Nanoliposomal L-Asparaginase and Its Antitumor Activities in Lewis Lung Carcinoma Tumor-Induced BALB/c Mice
by: Thi Thao Do, et al.
Published: (2019-01-01) -
Assessment of fluoride bio-accessibility in early childhood diets
by: Jelena Kronic, et al.
Published: (2025-02-01)